ONCT - Oncternal Therapeutics GAAP EPS of -$0.20 beats by $0.01 revenue of $0.17M misses by $0.11M March, 09 2023 04:03 PM Oncternal Therapeutics Inc. 2023-03-09 16:03:27 ET Oncternal Therapeutics press release ( NASDAQ: ONCT ): Q4 GAAP EPS of -$0.20 beats by $0.01 . Revenue of $0.17M misses by $0.11M . For further details see: Oncternal Therapeutics GAAP EPS of -$0.20 beats by $0.01, revenue of $0.17M misses by $0.11M